Cell–cell fusion of mesenchymal cells with distinct differentiations triggers genomic and transcriptomic remodelling toward tumour aggressiveness

Archive ouverte

Delespaul, Lucile | Gélabert, Caroline | Lesluyes, Tom | Le Guellec, Sophie | Pérot, Gaëlle | Leroy, Laura | Baud, Jessica | Merle, Candice | Lartigue, Lydia | Chibon, Frédéric

Edité par CCSD ; Nature Publishing Group -

International audience. Cell-cell fusion is a physiological process that is hijacked during oncogenesis and promotes tumour evolution. The main known impact of cell fusion is to promote the formation of metastatic hybrid cells following fusion between mobile leucocytes and proliferating tumour cells. We show here that cell fusion between immortalized myoblasts and transformed fibroblasts, through genomic instability and expression of a specific transcriptomic profile, leads to emergence of hybrid cells acquiring dissemination properties. This is associated with acquisition of clonogenic ability by fused cells. In addition, by inheriting parental properties, hybrid tumours were found to mimic the histological characteristics of a specific histotype of sarcomas: undifferentiated pleomorphic sarcomas with incomplete muscular differentiation. This finding suggests that cell fusion, as macroevolution event, favours specific sarcoma development according to the differentiation lineage of parent cells.

Suggestions

Du même auteur

Fusion-mediated chromosomal instability promotes aneuploidy patterns that resemble human tumors

Archive ouverte | Delespaul, Lucile | CCSD

International audience

Genome remodeling upon mesenchymal tumor cell fusion contributes to tumor progression and metastatic spread

Archive ouverte | Lartigue, Lydia | CCSD

International audience

ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas

Archive ouverte | Darmusey, Lucie | CCSD

International audience. Whole genome and transcriptome sequencing of a cohort of 67 leiomyosarcomas has been revealed ATRX to be one of the most frequently mutated genes in leiomyosarcomas after TP53 and RB1. While ...

Chargement des enrichissements...